WallStreetZenWallStreetZen

NASDAQ: STIM
Neuronetics Inc Stock

$6.43+0.04 (+0.63%)
Updated Feb 3, 2023
STIM Price
$6.43
Fair Value Price
$9.16
Market Cap
$175.03M
52 Week Low
$1.98
52 Week High
$6.95
P/E
-4.73x
P/B
2.78x
P/S
1.38x
PEG
N/A
Dividend Yield
N/A
Revenue
$62.03M
Earnings
-$36.51M
Gross Margin
76.4%
Operating Margin
-52.24%
Profit Margin
-58.9%
Debt to Equity
0.89
Operating Cash Flow
-$32M
Beta
1.25
Next Earnings
Mar 6, 2023
Ex-Dividend
N/A
Next Dividend
N/A

STIM Overview

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how STIM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

STIM ($6.43) is undervalued by 29.83% relative to our estimate of its Fair Value price of $9.16 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
STIM ($6.43) is significantly undervalued by 29.83% relative to our estimate of its Fair Value price of $9.16 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
STIM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more STIM due diligence checks available for Premium users.

Be the first to know about important STIM news, forecast changes, insider trades & much more!

STIM News

Valuation

STIM fair value

Fair Value of STIM stock based on Discounted Cash Flow (DCF)
Price
$6.43
Fair Value
$9.16
Undervalued by
29.83%
STIM ($6.43) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
STIM ($6.43) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
STIM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

STIM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.73x
Industry
37.84x
Market
15.09x

STIM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.78x
Industry
4.54x
STIM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

STIM's financial health

Profit margin

Revenue
$16.5M
Net Income
-$7.6M
Profit Margin
-46.1%
STIM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
STIM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$119.2M
Liabilities
$56.2M
Debt to equity
0.89
STIM's short-term assets ($101.10M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
STIM's short-term assets ($101.10M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
STIM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.5M
Investing
$9.3M
Financing
$0.0
STIM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

STIM vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
STIM$175.03M+0.63%-4.73x2.78x
PSNL$179.29M+28.29%-1.72x0.74x
DMTK$168.30M+0.91%-1.45x1.09x
LAB$164.94M+1.96%-0.90x-2.63x
BVS$163.25M-4.55%-1.02x0.48x

Neuronetics Stock FAQ

What is Neuronetics's quote symbol?

NASDAQ: STIM) Neuronetics trades on the NASDAQ under the ticker symbol STIM. Neuronetics stock quotes can also be displayed as NASDAQ: STIM.

If you're new to stock investing, here's how to buy Neuronetics stock.

What is the 52 week high and low for Neuronetics (NASDAQ: STIM)?

(NASDAQ: STIM) Neuronetics's 52-week high was $6.95, and its 52-week low was $1.98. It is currently -7.51% from its 52-week high and 224.75% from its 52-week low.

How much is Neuronetics stock worth today?

(NASDAQ: STIM) Neuronetics currently has 27,221,490 outstanding shares. With Neuronetics stock trading at $6.43 per share, the total value of Neuronetics stock (market capitalization) is $175.03M.

Neuronetics stock was originally listed at a price of $27.78 in Jun 28, 2018. If you had invested in Neuronetics stock at $27.78, your return over the last 4 years would have been -76.85%, for an annualized return of -30.64% (not including any dividends or dividend reinvestments).

How much is Neuronetics's stock price per share?

(NASDAQ: STIM) Neuronetics stock price per share is $6.43 today (as of Feb 3, 2023).

What is Neuronetics's Market Cap?

(NASDAQ: STIM) Neuronetics's market cap is $175.03M, as of Feb 7, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Neuronetics's market cap is calculated by multiplying STIM's current stock price of $6.43 by STIM's total outstanding shares of 27,221,490.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.